Hyperactivation of EGFR-dependent signal transduction usually accompanies tumor development, and cancer patients with unbalanced activation of EGFR generally present with a more aggressive disease leading to unfavorable clinical prognosis7. This evidence concerns the gene EGFR and neoplasm.